ArticleJournal of the advanced practitioner in oncology2025
Advanced Practice Provider-Led Trials in Radiation Oncology: Are We Missing the Opportunity?
Article in Journal of the advanced practitioner in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced practice providers (APPs) are integral members of radiation oncology care teams yet remain underrepresented in clinical research leadership. This article explores the barriers, opportunities, and strategic pathways for expanding APP-led research, particularly in patient-reported outcomes (PROs) and health services research. Despite APPs' daily proximity to symptom management, patient communication, and care delivery workflows, systemic challenges such as limited protected time, inconsistent credentialing policies, and lack of mentorship inhibit broader scholarly engagement. National initiatives like The Patient-Reported Outcomes Tools: Engaging Users and Stakeholders (PROTEUS) Consortium offer accessible tools and funding opportunities to promote rigorous, patient-centered PRO integration in trials and clinical practice. By aligning APP strengths with national research priorities and supporting protected time, mentorship, and clearer principal investigator pathways, institutions can unlock a critical avenue for innovation. Advancing APP-led research is not just an investment in professional development but also a strategic imperative to ensure radiation oncology research is as patient-centered, inclusive, and impactful as the care it aims to improve.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.